D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Ryan Specialty Holdings
RYAN
$5.61B
| $9.29M | 0.01% |
215,914
+24,803
| +13% | +$1.12M |
|
1302
Phinia Inc
PHIN
$2.85B
| $9.28M | 0.01% |
306,469
+195,381
| +176% | +$5.24M |
|
1303
PUT
GitLab
GTLB
$5.63B
| $9.28M | 0.01% |
147,400
+40,000
| +37% | +$2.02M |
|
1304
Silicon Laboratories
SLAB
$7.16B
| $9.27M | 0.01% |
70,096
-64,426
| -48% | -$7.05M |
|
1305
Weave Communications
WEAV
$533M
| $9.26M | 0.01% |
807,636
+87,326
| +12% | +$774K |
|
1306
Sensata Technologies
ST
$6.65B
| $9.26M | 0.01% |
246,470
+96,540
| +64% | +$3.34M |
|
1307
CALL
Alcoa
AA
$11.7B
| $9.25M | 0.01% |
272,000
+52,100
| +24% | +$1.41M |
|
1308
Green Dot
GDOT
$747M
| $9.22M | 0.01% |
930,823
+375,343
| +68% | +$3.91M |
|
|
SGI
1309
Somnigroup International
SGI
$15.4B
| $9.21M | 0.01% |
180,612
+164,234
| +1,003% | +$6.97M |
|
1310
PUT
Dollar Tree
DLTR
$23.9B
| $9.19M | 0.01% |
64,700
+30,500
| +89% | +$3.61M |
|
1311
Payoneer
PAYO
$2.41B
| $9.18M | 0.01% |
1,762,161
-120,812
| -6% | -$666K |
|
1312
PUT
Abbott
ABT
$183B
| $9.17M | 0.01% |
83,300
-35,800
| -30% | -$3.58M |
|
1313
PUT
Boston Properties
BXP
$11B
| $9.16M | 0.01% |
130,600
-18,800
| -13% | -$1.11M |
|
1314
CALL
Wolfspeed
WOLF
$1.17B
| $9.11M | 0.01% |
209,300
+50,000
| +31% | +$1.81M |
|
1315
Harmony Biosciences
HRMY
$2.09B
| $9.1M | 0.01% |
281,756
+13,943
| +5% | +$389K |
|
1316
Yum! Brands
YUM
$41B
| $9.09M | 0.01% |
69,586
-153,838
| -69% | -$19.2M |
|
1317
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.5B
| $9.09M | 0.01% |
+101,620
| New | +$8.42M |
|
1318
Adient
ADNT
$1.61B
| $9.08M | 0.01% |
+249,792
| New | +$8.57M |
|
|
HCVI
1319
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
| $9.07M | 0.01% |
870,000
| – | – |
|
|
AD
1320
Array Digital Infrastructure
AD
$3.02B
| $9.05M | 0.01% |
217,939
+117,772
| +118% | +$4.99M |
|
1321
Newmark Group
NMRK
$2.82B
| $9.04M | 0.01% |
824,510
-99,503
| -11% | -$752K |
|
1322
The Greenbrier Companies
GBX
$1.57B
| $9.04M | 0.01% |
204,522
+43,305
| +27% | +$1.69M |
|
1323
EnerSys
ENS
$6.84B
| $9.03M | 0.01% |
89,433
+52,512
| +142% | +$4.83M |
|
|
YMAB
1324
DELISTED
Y-mAbs Therapeutics
YMAB
| $9.03M | 0.01% |
1,323,780
-25,430
| -2% | -$147K |
|
|
TRTL
1325
DELISTED
TortoiseEcofin Acquisition Corp. III
TRTL
| $9.03M | 0.01% |
850,000
-2,120,000
| -71% | -$22.4M |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.